WestView Capital Partners-backed Kymanox to acquire Anteris Medical and Anteris Helvetia from Anteris.

WestView Capital Partners-backed Kymanox, a professional services company exclusively serving the life science industry, agreed to acquire Anteris Medical and Anteris Helvetia, both companies supports the pharmaceutical, biotech, and medical device industries globally. Financial terms were not disclosed. “We are excited about merging our capabilities with anteris, a nimble organization with an amazing reputation for being committed to their clients’ programs with a focus on results, which means getting critical treatments to patients-in-need. Furthermore, anteris’ physical presence in Germany and Switzerland, along with their strength and experience in biosimilars, fills two important strategic needs for Kymanox. The anteris team shares our core values of Quality + Integrity + Gratitude = Reputation, and brings a unique value proposition to the marketplace when combined with Kymanox’s capabilities. Together, we will support the development of vital modern medicines for people to live better, love longer, and Get More Done,” Stephen M. Perry, Kymanox Founder and CEO.